These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 2542344
1. Cholera toxin inhibits the increase in cytoplasmic free calcium induced via the CD2 pathway of human T-lymphocyte activation. Nunes J, Bagnasco M, Lopez M, Olive D, Mawas C. J Cell Biochem; 1989 Apr; 39(4):391-400. PubMed ID: 2542344 [Abstract] [Full Text] [Related]
2. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies. Bjorndahl JM, Sung SS, Hansen JA, Fu SM. Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432 [Abstract] [Full Text] [Related]
3. Cyclic AMP- and inositol phosphate-independent inhibition of Ca2+ influx by cholera toxin in CD3-stimulated Jurkat T cells. A study with a cholera toxin-resistant cell variant and the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. Gouy H, Cefai D, Christensen SB, Debre P, Bismuth G. J Immunol; 1991 Aug 01; 147(3):757-66. PubMed ID: 1650386 [Abstract] [Full Text] [Related]
4. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway. Anderson DL, Tsoukas CD. J Immunol; 1989 Dec 01; 143(11):3647-52. PubMed ID: 2555413 [Abstract] [Full Text] [Related]
5. Cholera toxin modulates the T cell antigen receptor/CD3 complex but not the CD2 molecule and inhibits signaling via both receptor structures in the human T cell lymphoma Jurkat. Sommermeyer H, Schwinzer R, Kaever V, Wessel K, Schmidt RE, Behl B, Wonigeit K, Szamel M, Resch K. Eur J Immunol; 1989 Dec 01; 19(12):2387-90. PubMed ID: 2575034 [Abstract] [Full Text] [Related]
6. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. Dang NH, Torimoto Y, Shimamura K, Tanaka T, Daley JF, Schlossman SF, Morimoto C. J Immunol; 1991 Nov 01; 147(9):2825-32. PubMed ID: 1717577 [Abstract] [Full Text] [Related]
7. cAMP inhibits the OKT3-induced increase in cytoplasmic free calcium in the Jurkat T cell line: the degree of inhibition correlates inversely with the amount of CD3 binding ligand used. Papadogiannakis N, Nordström TE, Andersson LC, Wolff CH. Eur J Immunol; 1989 Oct 01; 19(10):1953-6. PubMed ID: 2555197 [Abstract] [Full Text] [Related]
8. Regulation of the CD2 alternate pathway of T cell activation by CD3. Evidence for heterologous desensitization. Holter W, Majdic O, Stockinger H, Howard BH, Knapp W. J Immunol; 1988 Feb 15; 140(4):1043-6. PubMed ID: 2893822 [Abstract] [Full Text] [Related]
9. The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro. Bloemena E, Van Oers RH, Weinreich S, Stilma-Meinesz AP, Schellekens PT, Van Lier RA. Eur J Immunol; 1989 May 15; 19(5):943-6. PubMed ID: 2567675 [Abstract] [Full Text] [Related]
10. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule. Gerli R, Bertotto A, Crupi S, Arcangeli C, Marinelli I, Spinozzi F, Cernetti C, Angelella P, Rambotti P. J Immunol; 1989 Apr 15; 142(8):2583-9. PubMed ID: 2564856 [Abstract] [Full Text] [Related]
11. Regulation of CD2-mediated human T cell activation: anti-CD8 monoclonal antibodies inhibit CD2-mediated rise in intracellular calcium. Franco MD, Nunes J, Lipcey C, Lopez M, Mawas C, Olive D. Cell Immunol; 1993 Nov 15; 152(1):162-75. PubMed ID: 7902214 [Abstract] [Full Text] [Related]
12. Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin. Gouy H, Cefai D, Christensen SB, Debré P, Bismuth G. Eur J Immunol; 1990 Oct 15; 20(10):2269-75. PubMed ID: 1700752 [Abstract] [Full Text] [Related]
13. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. Ledbetter JA, Parsons M, Martin PJ, Hansen JA, Rabinovitch PS, June CH. J Immunol; 1986 Nov 15; 137(10):3299-305. PubMed ID: 3021852 [Abstract] [Full Text] [Related]
14. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. Dang NH, Torimoto Y, Sugita K, Daley JF, Schow P, Prado C, Schlossman SF, Morimoto C. J Immunol; 1990 Dec 15; 145(12):3963-71. PubMed ID: 1979581 [Abstract] [Full Text] [Related]
15. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways. Butler JJ, Mader JS, Watson CL, Zhang H, Blay J, Hoskin DW. J Cell Biochem; 2003 Aug 01; 89(5):975-91. PubMed ID: 12874832 [Abstract] [Full Text] [Related]
16. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C. Nel AE, Hanekom C, Rheeder A, Williams K, Pollack S, Katz R, Landreth GE. J Immunol; 1990 Apr 01; 144(7):2683-9. PubMed ID: 2156931 [Abstract] [Full Text] [Related]
17. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule. Gerli R, Agea E, Muscat C, Ercolani R, Bistoni O, Tognellini R, Mariggió MA, Spinozzi F, Bertotto A. Cell Immunol; 1994 Apr 15; 155(1):205-18. PubMed ID: 7909498 [Abstract] [Full Text] [Related]
18. Cholera toxin-mediated inhibition of signalling in Jurkat cells is followed by, but not due to a loss of T cell receptor complex. Sommermeyer H, Schwinzer R, Kaever V, Resch K. Immunobiology; 1991 Jun 15; 182(3-4):266-76. PubMed ID: 1655636 [Abstract] [Full Text] [Related]
19. Regulation of CD4 and CD8 surface expression on human thymocyte subpopulations by triggering through CD2 and the CD3-T cell receptor. Blue ML, Daley JF, Levine H, Branton KR, Schlossman SF. J Immunol; 1989 Jan 15; 142(2):374-80. PubMed ID: 2783435 [Abstract] [Full Text] [Related]
20. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants. Yang SY, Chouaib S, Dupont B. J Immunol; 1986 Aug 15; 137(4):1097-100. PubMed ID: 2426350 [Abstract] [Full Text] [Related] Page: [Next] [New Search]